Uncompromised NK cell activation is essential for virus-specific CTL activity during acute influenza virus infection

Cellular and Molecular Immunology

Volumn 15, Issue 9, 2018, Pages 827-837

  Liu, Yuan ^a,b   Zheng, Jian ^a   Liu, Yinping ^a   Wen, Liyan ^a   Huang, Lei ^c   Xiang, Zheng ^a   Lam, Kwok Tai ^a   Lv, Aizhen ^a   Mao, Huawei ^a,d   Lau, Yu Lung ^a   Tu, Wenwei ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b GUANGDONG WOMEN AND CHILDREN HOSPITAL   (China)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d THE UNIVERSITY OF HONG KONG SHENZHEN HOSPITAL   (China)

Author keywords

CTL; influenza; NK cell

Indexed keywords

GAMMA INTERFERON;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; IMMUNE EVASION; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; VIRUS IMMUNITY; ANIMAL; BAGG ALBINO MOUSE; IMMUNOLOGY; INFLUENZA A VIRUS; ORTHOMYXOVIRUS INFECTION; PATHOLOGY;

ANIMALS; FEMALE; INFLUENZA A VIRUS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 85045520727     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2017.10     Document Type: Article

References (43)

1. Medina RA, Garcia-Sastre A. Influenza A viruses: new research developments. Nat Rev Microbiol 2011; 9: 590–603.
2. Duggal NK, Emerman M. Evolutionary conflicts between viruses and restriction factors shape immunity. Nat Rev Immunol 2012; 12: 687–695.
3. Schmolke M, Garcia-Sastre A. Evasion of innate and adaptive immune responses by influenza A virus. Cell Microbiol 2010; 12: 873–880.
4. Varga ZT, Grant A, Manicassamy B, Palese P. Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential. J Virol 2012; 86: 8359–8366.
5. Conenello GM, Tisoncik JR, Rosenzweig E, Varga ZT, Palese P, Katze MG. A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo. J Virol 2011; 85: 652–662.
6. Varga ZT, Ramos I, Hai R, Schmolke M, Garcia-Sastre A, Fernandez-Sesma A et al. The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog 2011; 7: e1002067.
7. Ramos I, Carnero E, Bernal-Rubio D, Seibert CW, Westera L, Garcia-Sastre A et al. Contribution of double-stranded RNA and CPSF30 binding domains of influenza virus NS1 to the inhibition of type I interferon production and activation of human dendritic cells. J Virol 2013; 87: 2430–2440.
8. Fernandez-Sesma A, Marukian S, Ebersole BJ, Kaminski D, Park MS, Yuen T et al. Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol 2006; 80: 6295–6304.
9. Draghi M, Pashine A, Sanjanwala B, Gendzekhadze K, Cantoni C, Cosman D et al. NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection. J Immunol 2007; 178: 2688–2698.
10. Abdul-Careem MF, Mian MF, Yue G, Gillgrass A, Chenoweth MJ, Barra NG et al. Critical role of NK cells in lung immunopathology during influenza infection in mice. J Infect Dis 2012; 206: 167–177.
11. Zhou G, Juang SW, Kane KP. NK cells exacerbate the pathology of influenza virus infection in mice. Eur J Immunol 2013; 43: 929–938.
12. Tian Z, Zhang C. Natural Killer Cells. Springer: Berlin, Germany. 2010, 369–389.
13. Zingoni A, Cerboni C, Ardolino M, Santoni A. Natural Killer Cells. Springer: Berlin, Germany. 2010, 315–327.
14. Kos FJ, Engleman EG. Requirement for natural killer cells in the induction of cytotoxic T cells. J Immunol 1995; 155: 578–584.
15. Kos FJ, Engleman EG. Role of natural killer cells in the generation of influenza virus-specific cytotoxic T cells. Cell Immunol 1996; 173: 1–6.
16. Brandstadter JD, Yang Y. Natural killer cell responses to viral infection. J Innate Immun 2011; 3: 274–279.
17. Ge MQ, Ho AW, Tang Y, Wong KH, Chua BY, Gasser S et al. NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-γ and perforin-dependent mechanisms. J Immunol 2012; 189: 2099–2109.
18. Deniz G, Erten G, Kucuksezer UC, Kocacik D, Karagiannidis C, Aktas E et al. Regulatory NK cells suppress antigen-specific T cell responses. J Immunol 2008; 180: 850–857.
19. Soderquest K, Walzer T, Zafirova B, Klavinskis LS, Polic B, Vivier E et al. Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses. J Immunol 2011; 186: 3304–3308.
20. Mao H, Tu W, Qin G, Law HKW, Sia SF, Chan PL et al. Influenza virus directly infects human natural killer cells and induces cell apoptosis. J Virol 2009; 83: 9215–9222.
21. Guo H, Kumar P, Moran TM, Garcia-Sastre A, Zhou Y, Malarkannan S. The functional impairment of natural killer cells during influenza virus infection. Immunol Cell Biol 2009; 87: 579–589.
22. Manicassamy B, Manicassamy S, Belicha-Villanueva A, Pisanelli G, Pulendran B, Garcia-Sastre A. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci USA 2010; 107: 11531–11536.
23. Mao H, Tu W, Liu Y, Qin G, Zheng J, Chan PL et al. Inhibition of human natural killer cell activity by influenza virions and hemagglutinin. J Virol 2010; 84: 4148–4157.
24. Powell TJ, Dwyer DW, Morgan T, Hollenbaugh JA, Dutton RW. The immune system provides a strong response to even a low exposure to virus. Clin Immunol 2006; 119: 87–94.
25. Hatta Y, Hershberger K, Shinya K, Proll SC, Dubielzig RR, Hatta M et al. Viral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in mice. PLoS Pathog 2010; 6: e1001139.
26. Marois I, Cloutier A, Garneau E, Richter MV. Initial infectious dose dictates the innate, adaptive, and memory responses to influenza in the respiratory tract. J Leukoc Biol 2012; 92: 107–121.
27. Tu W, Zheng J, Liu Y, Sia SF, Liu M, Qin G et al. The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a γδ T cell population in humanized mice. J Exp Med 2011; 208: 1511–1522.
28. Zheng J, Liu Y, Liu Y, Liu M, Xiang Z, Lam KT et al. Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice. Sci Transl Med 2013; 5: 168ra169.
29. Fischer AH, Jacobson KA, Rose J, Zeller R. Hematoxylin and eosin staining of tissue and cell sections. CSH Protoc 2008; 2008: pdb.prot4986.
30. Vaknin I, Blinder L, Wang L, Gazit R, Shapira E, Genina O et al. A common pathway mediated through Toll-like receptors leads to T- and natural killer-cell immunosuppression. Blood 2008; 111: 1437–1447.
31. Byers AM, Kemball CC, Moser JM, Lukacher AE. Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells. J Immunol 2003; 171: 17–21.
32. Nogusa S, Ritz BW, Kassim SH, Jennings SR, Gardner EM. Characterization of age-related changes in natural killer cells during primary influenza infection in mice. Mech Ageing Dev 2008; 129: 223–230.
33. Verbist KC, Rose DL, Cole CJ, Field MB, Klonowski KD. IL-15 participates in the respiratory innate immune response to influenza virus infection. PLoS One 2012; 7: e37539.
34. Hao X, Kim TS, Braciale TJ. Differential response of respiratory dendritic cell subsets to influenza virus infection. J Virol 2008; 82: 4908–4919.
35. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 2002; 360: 1831–1837.
36. Regoes RR, Barber DL, Ahmed R, Antia R. Estimation of the rate of killing by cytotoxic T lymphocytes in vivo. Proc Natl Acad Sci USA 2007; 104: 1599–1603.
37. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 2002; 195: 327–333.
38. Piccioli D, Sbrana S, Melandri E, Valiante NM. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 2002; 195: 335–341.
39. Hardy MY, Kassianos AJ, Vulink A, Wilkinson R, Jongbloed SL, Hart DN et al. NK cells enhance the induction of CTL responses by IL-15 monocyte-derived dendritic cells. Immunol Cell Biol 2009; 87: 606–614.
40. Vankayalapati R, Klucar P, Wizel B, Weis SE, Samten B, Safi H et al. NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen. J Immunol 2004; 172: 130–137.
41. Hanna J, Gonen-Gross T, Fitchett J, Rowe T, Daniels M, Arnon TI et al. Novel APC-like properties of human NK cells directly regulate T cell activation. J Clin Invest 2004; 114: 1612–1623.
42. Krebs P, Barnes MJ, Lampe K, Whitley K, Bahjat KS, Beutler B et al. NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses. Blood 2009; 113: 6593–6602.
43. Stadnisky MD, Xie X, Coats ER, Bullock TN, Brown MG. Self MHC class I-licensed NK cells enhance adaptive CD8 T-cell viral immunity. Blood 2011; 117: 5133–5141.